Audit Committee Chair & Independent Board Director
Current
Nov 2023 - Present
AeroLeads people directory · profile
Susan Graf Email & Phone Number
Chief Executive Officer | Corporate Strategist | Company Builder | Deal Maker
at
CG Oncology
1 work email found
@roche.com
3 phones found area 617
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Chief Executive Officer | Corporate Strategist | Company Builder | Deal Maker
Location
Greater Boston, United States, United States
Who is Susan Graf? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Susan Graf is listed as Chief Executive Officer | Corporate Strategist | Company Builder | Deal Maker at CG Oncology, based in Greater Boston, United States, United States. AeroLeads shows a work email signal at roche.com, phone signal with area code 617, and a matched LinkedIn profile for Susan Graf.
Susan Graf previously worked as Audit Committee Chair & Independent Board Director at Cg Oncology and Audit Committee Chair & Board Member at Kaléo. Susan Graf holds Mba, Finance And Marketing from Nyu Stern School Of Business.
Company email context
Email format at CG Oncology
This section adds company-level context without repeating Susan Graf's masked contact details.
{first_initial}{last}@roche.com
76% confidence
AeroLeads found 1 current-domain work email signal for Susan Graf. Compare company email patterns before reaching out.
Profile bio
About Susan Graf
Accomplished global biopharma executive with broad industry experience in large pharma, mid-cap biotech and entrepreneurial startups. Driven to bring impactful products to patients in need and passionate about building and leading such companies. Praised for business acumen, strategic agility and functional expertise in corporate strategy, deal making, M&A, financing and the development and commercialization of biopharmaceuticals. Recognized as a leader that develops talent through genuine mentoring and coaching and engenders the trust of her team and respect from her colleagues through honest, transparent communication. • Broad corporate growth and company building experience: pre-clinical through commercial stage.• Skilled global manager leading through change & with resource constraints.• Extensive deal making expertise: acquisitions, product & discovery deals, both buy-side and sell-side.• Relevant capital-raising experience and credibility with investors and analysts.• Impactful Board of Directors interface: strategic planning, audit committee and M&A defense.• Track record of delivery.
Listed skills include Pharmaceutical Industry, Biopharmaceuticals, Competitive Intelligence, Market Research, and 26 others.
Current workplace
Susan Graf's current company
Company context helps verify the profile and gives searchers a useful next step.
18 roles · 31 years
Susan Graf work experience
A career timeline built from the work history available for this profile.
Audit Committee Chair & Board Member
Current
Dec 2021 - Present
Senior Advisor & Entrepreneur In Residence
Current
May 2021 - Present
Board Chair & Audit Committee Chair
Current
Apr 2021 - Present
Chief Executive Officer & Board Member
Akamara Therapeutics
Aug 2019 - May 2021
Member Board Of Directors
Jan 2017 - Sep 2019
Executive Advisor
Advised executive team of a clinical-stage, rare disease public company (NASDAQ: SLDB) on a variety of corporate development and transaction opportunities in the Duchenne muscular dystrophy space.
Jan 2019 - Aug 2019
Chief Business Officer & Principal Financial Officer
Epizyme
Member of a public company (NASDAQ: EPZM) executive team that advanced a lead cancer program into multiple phase 2 studies, identified NDA paths and accelerated novel pre-clinical programs toward the clinic. Accountable for corporate strategy, fund raising and finance (planning, operations and SEC reporting), business development, alliance management.
Apr 2016 - Sep 2018
Vice President, Corporate Development & Strategy
Member of the NPS Pharma Executive Team (NASDAQ: NPSP) that led the transformation from a US-focused, development-stage, 130-person, $1.5B market cap rare disease biopharmaceutical company to a global, two commercial product, 375-person, $5.2B market cap company. Brought to NPS to build the Corporate Development and Strategy function. Accountable for.
May 2013 - Mar 2015
Global Head, Commercial Assessment And Due Diligence
Member of Pharma Partnering Leadership Team; led a global group accountable for the business, technical and scientific assessment of all licensing and acquisition deals that Roche reviews and transacts upon. Concluded 3 transactions, with associated de-risking plans, gaining access to 4 new clinical stage products in a challenging deal making environment.
Jan 2011 - Dec 2012
Global Head (Executive Director), Strategic Evaluation
Promoted to manage a global business assessment team through a challenging period, including integration of Genentech and one corporate downsizing. Ensured department’s ability to assess and close quality licensing and acquisition deals despite environmental challenges, such as Genentech integration disruption. Concluded 5 transactions, gaining access to 6.
Sep 2009 - Jan 2011
Director, Global Business Development, Mergers And Acquisitions
Mergers and acquisitions project leader. Responsible for sourcing, assessing and closing deals, including initial integration plan. Provided decision-enabling analysis and recommendations to senior management for all sizes and types of M&A opportunities. Identified M&A targets and led numerous product and technology acquisitions for the Pharma Division to.
Apr 2008 - Sep 2009
Director, Marketing
Accountable for successful launch of MIRCERA in the U.S. Managed individuals responsible for key tactical elements of the brand plan (Reimbursement, Medical Liaison & sales training, US market product packaging).
2005 - 2008
~3 yrs
Director, Business Development
Developed licensing strategies, identified external products, served as key contact with prospective partners and led deal teams in structuring, negotiating and closing deals. Championed numerous licensing opportunities and closed 2 key deals.
2003 - 2005
~2 yrs
Manager, Business Development
2000 - 2003
~3 yrs
Market Analyst, New Product Planning
1998 - 2000
~2 yrs
Medical Center Representative
1996 - 1998
~2 yrs
Validation Engineer, Manufacturing
1995 - 1996
~1 yr
2 education records
Susan Graf education
Mba, Finance And Marketing
Nyu Stern School Of Business
Bs, Pharmacy
Purdue University
FAQ
Frequently asked questions about Susan Graf
Quick answers generated from the profile data available on this page.
What company does Susan Graf work for?
Susan Graf works for CG Oncology.
What is Susan Graf's role at CG Oncology?
Susan Graf is listed as Chief Executive Officer | Corporate Strategist | Company Builder | Deal Maker at CG Oncology.
What is Susan Graf's email address?
AeroLeads has found 1 work email signal at @roche.com for Susan Graf at CG Oncology.
What is Susan Graf's phone number?
AeroLeads has found 3 phone signal(s) with area code 617 for Susan Graf at CG Oncology.
Where is Susan Graf based?
Susan Graf is based in Greater Boston, United States, United States while working with CG Oncology.
What companies has Susan Graf worked for?
Susan Graf has worked for Cg Oncology, Kaléo, Locust Walk, Finch Therapeutics, and Akamara Therapeutics.
How can I contact Susan Graf?
You can use AeroLeads to view verified contact signals for Susan Graf at CG Oncology, including work email, phone, and LinkedIn data when available.
What schools did Susan Graf attend?
Susan Graf holds Mba, Finance And Marketing from Nyu Stern School Of Business.
What skills is Susan Graf known for?
Susan Graf is listed with skills including Pharmaceutical Industry, Biopharmaceuticals, Competitive Intelligence, Market Research, Product Launch, Cross Functional Team Leadership, Oncology, and Market Analysis.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial